A Study of the Safety of Individualized Combination Therapy With Copegus (Ribavirin) and Pegasys (Peginterferon Alfa-2a) in Patients With Chronic Hepatitis C (MASTER)
PHASE3
This open-label, non-comparative study will assess the safety and tolerabil...
Combination Therapy With Pegylated Interferon and Ribavirin in Patients With Chronic Hepatitis C Genotype 2 or 3 Infection Who Previously Have Relapsed After Therapy With Pegylated Interferon and Ribavirin
PHASE4
To evaluate the efficacy of pegylated interferon alfa-2a 40 kD (PEGASYS) co...
Status
Terminated
Location
Dept of Infectious Diseases, Sahlgrenska University Hospital
An Observational Study in Participants With Chronic Hepatitis B (CHB) Receiving Therapy With Peginterferon Alfa-2a 40 Kilodaltons (kD) (PEGASYS) - The PRO B Study
N/A
This open--label, multicenter, national observational study will investigat...
Peak Study - A Study of Pegasys (Peginterferon Alfa-2a (40KD)) in Combination With Copegus (Ribavirin) in Interferon-Naive Patients With Chronic Hepatitis C (CHC).
PHASE4
This study will examine the viral kinetics and pharmacokinetics of Pegasys ...